KeasClinical Studies ApS
CVR 40794492 · Private limited company (ApS) · Active · Low risk
KeasClinical Studies ApS is a Private limited company (ApS), founded on , based in Aarhus C. The company is registered in the industry andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. Our model estimates a bankruptcy risk of 0.4% over the next 12 months, which is 0.3 times the average for Danish companies. 6 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 78k and a net result of DKK -14k. CEO: Lone Bliksted Gitz-Johansen.
Bankruptcy risk for KeasClinical Studies ApS
0.3 × the average (1.41%) · higher risk than 57% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 40794492
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (7 years)
- Address
- Holger Drachmanns Vej 6
8000 Aarhus C - Municipality
- Aarhus
- Industry
- Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n. (749990)
Bankruptcies in the industry: Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n. - Share capital
- DKK 40k
- Auditor
- TANGSTAD - STATSAUTORISERET REVISIONSANPARTSSELSKAB
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 0 of 6 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 58.0% |
| Current ratio | 238% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 2 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 2 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK -23k | DKK -658 | DKK -7,500 |
| Net profit | DKK -14k | DKK -607 | DKK -7,486 |
| Equity | DKK 78k | DKK 93k | DKK 93k |
| Total assets | DKK 135k | DKK 122k | DKK 101k |
| Cash | DKK 23k | DKK 20k | – |
| Short-term debt | DKK 57k | DKK 29k | – |
| Avg. employees | 1 | – | – |
Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · TANGSTAD - STATSAUTORISERET REVISIONSANPARTSSELSKAB.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 176 | ||
| 1 Jan 2024 – 31 Dec 2024 | 15 | ||
| 1 Jan 2023 – 31 Dec 2023 | 182 | ||
| 1 Jan 2022 – 31 Dec 2022 | 26 | ||
| 1 Jan 2021 – 31 Dec 2021 | 181 | ||
| 18 Sep 2019 – 31 Dec 2020 | 110 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Lone Bliksted Gitz-Johansen | Current | |
| CEO | Janus Bliksted Gitz-Johansen | ||
| Owner (5%) | Mette Albinus Grønbæk | Current | |
| Owner (90%) | Blitz Holding ApS | Current | |
| Owner (100%) | Blitz Holding ApS | ||
| Founder | Blitz Holding ApS | Current |
The CEOs' other companies
Lone Bliksted Gitz-Johansen – 1 other companies
- KeasCare ApS Active
Janus Bliksted Gitz-Johansen – 4 other companies
- Blitz Holding ApS Active
- Insights Tech ApS Active
- KeasCare ApS Active
- Transire ApS Opløst
Address history (0 moves)
| Holger Drachmanns Vej 6, 8000 Aarhus C |
Former names
| KeasClinical Studies ApS | – now |
| Blitz Technology ApS | – |
Other companies at the same address
- Blitz Holding ApS Active
- Transire ApS Opløst
Similar companies in Aarhus
- DGE A/S Højbjerg
- JR-HEALTHnSAFETY ApS Skødstrup
- Tingvej 15 ApS Aarhus V
- Kalkuleret ApS Skødstrup
- Dansk Vejrens ApS Egå
- RLstatLab ApS Højbjerg
- Copenhagen Genetics ApS Risskov
- VKJ Group ApS Brabrand
- Arne Sørensen Energikonsulent ApS Solbjerg
- Torben Bloksgaard ApS Højbjerg
- RE-ZIP DK ApS Aarhus N
- NATTORALIK A/S Højbjerg
Questions and answers about KeasClinical Studies ApS
Has KeasClinical Studies ApS gone bankrupt?
No, KeasClinical Studies ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of KeasClinical Studies ApS?
Our model estimates a bankruptcy risk of 0.4% over the next 12 months (low risk), which is 0.3 times the average for Danish companies.
Who is the CEO of KeasClinical Studies ApS?
Lone Bliksted Gitz-Johansen is the CEO of KeasClinical Studies ApS.
Who is the auditor of KeasClinical Studies ApS?
KeasClinical Studies ApS most recently used TANGSTAD - STATSAUTORISERET REVISIONSANPARTSSELSKAB.
When was KeasClinical Studies ApS founded?
KeasClinical Studies ApS was founded on 18 September 2019.
What is the equity of KeasClinical Studies ApS?
Equity was DKK 78k according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.